On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era

D. Busschots*, R. Bielen, O.M. Koc, L. Heyens, E. Dercon, R. Verrando, F. Janssens, L. Van den Bergh, P. Van Lint, L. Bruckers, F. Nevens, G. Robaeys

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1574
Number of pages9
JournalBMC Public Health
Volume21
Issue number1
DOIs
Publication statusPublished - 20 Aug 2021

Keywords

  • Hepatitis C
  • People who use drugs
  • Case management
  • Opioid agonist therapy
  • Care cascade
  • High-income country
  • INJECT DRUGS
  • GENERAL-PRACTICE
  • VIRUS-INFECTION
  • RANDOMIZED-TRIAL
  • PEOPLE
  • HCV
  • INTERVENTIONS
  • INTERFERON
  • SETTINGS
  • MODEL

Cite this